Logo only.png

Phages for a healthier world

We develop innovative bacteriophage-based products to help the world's most vulnerable communities prosper.

 

PhagePro is an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the world’s most vulnerable communities. We are a discovery-driven venture spun out of the Camilli Lab at Tufts University School of Medicine in Boston. PhagePro aims to use bacteriophages, which are viruses that specifically target and kill bacteria, to prevent bacterial infections.

 

 
 

About

Find out about our organization, mission, and our projects.

Learn More →

Contact us

Interested in finding out more?  Contact us with your questions and comments!

E-mail Us →